Sengenics Revenue and Competitors
Estimated Revenue & Valuation
- Sengenics's estimated annual revenue is currently $11.2M per year.
- Sengenics's estimated revenue per employee is $155,000
Employee Data
- Sengenics has 72 Employees.
- Sengenics grew their employee count by -9% last year.
Sengenics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | VP Market and Business Development | Reveal Email/Phone |
3 | Head EU & UK | Reveal Email/Phone |
4 | Head (Europe) Business Unit | Reveal Email/Phone |
5 | Head Bioinformatics, Sengenics | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | President & CEO, Board Director | Reveal Email/Phone |
8 | Sales Director - Northern Europe | Reveal Email/Phone |
9 | Global Director Corporate Strategy | Reveal Email/Phone |
10 | Senior Marketing Content Manager | Reveal Email/Phone |
Sengenics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.9M | 63 | -24% | $15M | N/A |
#2 | $20M | 129 | -16% | $150M | N/A |
#3 | $3.7M | 48 | -6% | $53M | N/A |
#4 | $5.4M | 35 | -8% | N/A | N/A |
#5 | $3.6M | 23 | -18% | N/A | N/A |
#6 | $3.4M | 22 | 0% | N/A | N/A |
#7 | $5.4M | 35 | 6% | N/A | N/A |
#8 | $7.1M | 46 | -26% | N/A | N/A |
#9 | $36.1M | 233 | 4% | N/A | N/A |
#10 | $3.1M | 20 | -61% | N/A | N/A |
What Is Sengenics?
Sengenics is a functional proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREXâ„¢ was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge. Jonathan is the CSO of Sengenics. The key application of KREXâ„¢ is the discovery of autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREXâ„¢ can also be used to identify autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions years before conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.
keywords:N/A
N/A
Total Funding
72
Number of Employees
$11.2M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sengenics News
... Outlook And Forecast | Illumina TruSeq Exome, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene.
... Life Technologies, Roche NimbleGen, Agilent Technologies, BGI, Eurofins Genomics, Sengenics, GENEWIZ, Knome, Macrogen, Ambry Genetics.
Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our...
Other Companies in Singapore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.4M | 72 | -11% | N/A |
#2 | $8.4M | 72 | -17% | N/A |
#3 | $9.4M | 72 | -4% | N/A |
#4 | $9.1M | 72 | N/A | N/A |
#5 | $8.4M | 72 | -35% | N/A |